U-Blot® Research Grade Tamtuvetmab

Name: U-Blot® Research Grade Tamtuvetmab
SKU: WA3609
Availability: InStock

$9,999.00

Size:50ug

SKU: WA3609-50

Catalog No.: WA3609

Specification: 50ug/100ug

Stock: In stock

Product details, specifications, documents, and related products are available from the catalog record. Learn more

Product details Specifications Q & A Education

Product details, specifications, documents, and related products are available from the catalog record.

Product Overview

Catalog No.: WA3609
SKU: WA3609-50
Category: Biosimilar Antibodies
Product Type: Other
Size: 50ug/100ug
Stock Status: In stock
Available Stock: 999
Minimum Order Quantity: 1

Storage & Compliance

Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Research Use Only: Yes

Additional Specifications

PackSize: 50ug/100ug
Target: CD52
Reactivity: Dog
Applications: ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Host Species: Caninized
Isotype: IgG2-kappa-lambda
Conjugate/Modification: --
Recommended Dilution Ratio: --
Composition: 0.01M PBS, pH 7.4.
Purification Process: Protein A/G purified from cell culture supernatant.
Purity: >95% purity as determined by SDS-PAGE.
storageCondition: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Clonality: Monoclonal
Clone Number: --
Immunogen: Mammalian Cells
Alias: CD52
Species: --
Gene ID-1: Q28896
Uniprot: --
Background: Tamtuvetmab (AT-005) is a caninised blontuvetmab against CD52. Tamtuvetmab increases progression-free survival (PFS), exhibits in vivo efficacy in dogs with naïve T-cell lymphoma (LSA). Tamtuvetmab has been approved by veterinary. • CD52 antigen--a review., PMID:11257744 • Anti-CD52 Therapy for Multiple Sclerosis: An Update in the COVID Era., PMID:34268256 • CD52 mRNA expression predicts prognosis and response to immune checkpoint blockade in melanoma., PMID:37975535 • ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Agents targeting lymphoid cells surface antigens [I]: CD19, CD20 and CD52)., PMID:29447988 • Surface CD52, CD84, and PTGER2 mark mature PMN-MDSCs from cancer patients and G-CSF-treated donors., PMID:38242120 • The immunological function of CD52 and its targeting in organ transplantation., PMID:28283679 • CD52 (CAMPATH1)., PMID:11860230 • Preoperative CD52 Level Predicts Graft Survival following Kidney Transplantation., PMID:39281063 • CD52 and OXPHOS-potential targets in ibrutinib-treated mantle cell lymphoma., PMID:36587029 • CD52-targeted depletion by Alemtuzumab ameliorates allergic airway hyperreactivity and lung inflammation., PMID:33731828
Tissue Expression: --
Signaling_pathway: --
Research Areas: --

Tech Support

ucallm

Documents

Datasheet, COA, SDS, and protocol files can be requested from technical support.

Storage & Handling

Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.